Skye Bioscience, Inc. (SKYE)
0.698
+0.03
(+4.98%)
USD |
NASDAQ |
Apr 02, 16:00
0.6895
-0.01
(-1.22%)
After-Hours: 20:00
Skye Bioscience Shareholders Equity (Quarterly) : 20.02M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 48.81M |
| Merck & Co., Inc. | 52.61B |
| SIGA Technologies, Inc. | 198.82M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.31M |
| Total Liabilities (Quarterly) | 8.290M |
| Debt to Equity Ratio | 0.0137 |
| Current Ratio | 3.302 |
| Net Debt Paydown Yield | -0.07% |